RS BioTherapeutics Adds Jane Wright-Mitchell, Pharm.D., J.D. to Business Advisory Board
April 25, 2024 10:00 ET
|
RS BioTherapeutics
RS BioTherapeutics is pleased to announce the addition of Jane Wright-Mitchell, Pharm.D., J.D. to the RS BioTherapeutics Business Advisory Board.
Foundation for Sarcoidosis Research and Walgreens Unite in Alabama to Boost Sarcoidosis Awareness and Spring Vaccine Education for April Awareness Month
April 15, 2024 18:31 ET
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research Partners with Walgreens in Alabama to Raise Awareness for Sarcoidosis and Spring Vaccines
Foundation for Sarcoidosis Research Launches Say Sarcoidosis Campaign to Shed Light on the 1.2 Million People Impacted by Sarcoidosis for April’s Awareness Month
April 01, 2024 07:41 ET
|
Foundation for Sarcoidosis Research
FSR Launches Say Sarcoidosis campaign for April's Awareness Month
RS BioTherapeutics Creates Therapeutic Expert Council to Provide Guidance on Development of First-in-Class Agent Focused on Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
February 21, 2024 09:52 ET
|
RS BioTherapeutics
RS BioTherapeutics is pleased to announce the formation of its Therapeutic Expert Council (TEC).
RS BioTherapeutics Promotes Michelle L. Shuffett, MD to Chief Medical Officer
October 31, 2023 11:00 ET
|
RS BioTherapeutics
RS BioTherapeutics is pleased to announce that it has appointed Michelle L. Shuffett, MD as its Chief Medical Officer.
Foundation for Sarcoidosis Research announces largest Global Sarcoidosis Virtual Summit – Find Your Community, Find Your Life
September 26, 2023 09:15 ET
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research to Host Largest Virtual Sarcoidosis Educational Event of the Year
Physiotherapy Equipment Market to reach USD 40.3 billion by 2032, says Global Market Insights Inc.
June 27, 2023 07:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, June 27, 2023 (GLOBE NEWSWIRE) -- Physiotherapy Equipment Market size is estimated to record USD 40.3 billion by 2032. The increasing prevalence of chronic diseases,...
Pharmaceutical Drug Delivery Market to hit USD 3.2 Trillion by 2032, says Global Market Insights Inc.
May 03, 2023 08:10 ET
|
Global Market Insights Inc.
Selbyville, Delaware, May 03, 2023 (GLOBE NEWSWIRE) -- The pharmaceutical drug delivery market value is predicted to reach over USD 3.2 trillion by 2032, according to a new research report by...
InCarda Therapeutics Announces Enrollment of First Patient in Pivotal Phase 3 RESTORE-1 Trial of InRhythm™ for the Treatment of Paroxysmal Atrial Fibrillation
July 26, 2022 07:00 ET
|
InCarda Therapeutics, Inc.
Single Pivotal Phase 3 Trial to Support Filing of New Drug Application Positive Phase 2 Efficacy and Safety Data for InRhythm Recently Highlighted as “Editor’s Pick” in Circulation: Arrhythmia...
With Monaghan Medical, Safe Nebulizer Therapy is Possible
February 23, 2021 08:40 ET
|
Monaghan Medical Corporation
PLATTSBURGH, N.Y., Feb. 23, 2021 (GLOBE NEWSWIRE) -- Monaghan Medical Corporation wants you to know that you can create a safer environment when delivering nebulizer therapy. Nebulizer therapy is a...